Bard 1 Ovarian-assay development completed, 22 peptide RUO kits delivered. So, it is de-risked as it is capable of being used on Luminex instrumentation(using procarta plex technology) and optimisation is progressing. Extended agreement with Thermo Fisher and expect Luminex to be there soon for the commercial development.
Bard 1 Breast Cancer is inextricably linked with Bard 1 Ovarian-same autoantibody test.
Bard 1 Lung is well progressed for coming assay development on Luminex platform.
Thoughts on BD1?, page-12
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M | |||
| Open | High | Low | Value | Volume |
| 59.5¢ | 59.5¢ | 58.0¢ | $4.527K | 7.767K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 38600 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 59.0¢ | 198 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |